SCHEMBL20839656

SCHEMBL20839656

CC(=O)CCCCCCC(=O)NC(C(=O)NC(CCCNC(N)=O)C(=O)Nc1ccc(CO)cc1)C(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 5/20 0.42
NPY4R P50391 5/20 0.42
NPY1R P25929 4/20 0.42
NPY2R P49146 2/20 0.42
FURIN P09958 3/20 0.40
ROCK2 O75116 1/20 0.39
NMT2 O60551 1/20 0.38
NMT1 P30419 1/20 0.38
HTT P42858 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
HDAC1 Q13547 2/20 0.37
HDAC3 O15379 1/20 0.37
HDAC4 P56524 1/20 0.37
HDAC7 Q8WUI4 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC11 Q96DB2 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
HDAC9 Q9UKV0 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17312902 0.95 FURIN (0.41) NPY5RNPY4RNPY1RNPY2RFURIN
SCHEMBL14978855 0.94 NMT2 (0.45) NPY5RNPY4RNPY1RNPY2RFURIN
SCHEMBL15692124 0.94 NMT2 (0.45) NPY5RNPY4RNPY1RNPY2RFURIN
SCHEMBL23355149 0.92 CTSL (0.42) NPY5RNPY4RNPY1RNPY2RFURIN
SCHEMBL24864421 0.90 NPY5R (0.40) NPY5RNPY4RNPY1RNPY2RFURIN
SCHEMBL24270749 0.90 FURIN (0.43) FURINHTT
SCHEMBL21897658 0.90 NPY4R (0.40) NPY5RNPY4RNPY1RNPY2RFURIN
SCHEMBL16645084 0.90 ROCK2 (0.43) NPY5RNPY4RNPY1RNPY2RFURIN
SCHEMBL20512995 0.89 HTT (0.45) NPY5RNPY4RNPY1RNPY2RFURIN
SCHEMBL20512998 0.89 HTT (0.45) NPY5RNPY4RNPY1RNPY2RFURIN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250049904-A1 IMMUNOSTIMULATORY COMPOSITIONS MALCORP BIODISCOVERIES LIMITED (NZ) 2025-02-13 US disclosed
WO-2023121483-A1 IMMUNOSTIMULATORY COMPOSITIONS VICTORIA LINK LIMITED (NZ) 2023-06-29 WO disclosed
WO-2019058289-A1 MAIT CELL AGONISTS VICTORIA LINK LIMITED (NZ) 2019-03-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250049904-A1 IMMUNOSTIMULATORY COMPOSITIONS CD69, PBK, GALK1 NPY5R 1741/4885NPY4R 1068/4885NPY1R 1106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.